CAH
69
2
CNX
53
3
CMS
67
9
ADM
42
5
PX
69
-3
ECL
45
-2
AMG
68
-7
PEP
27
-2
PFE
23
-5
OMC
40
-2
MCHP
62
11
SBUX
37
-2
WFC
75
-4
MAR
72
-2
WU
30
-2
LOW
53
-3
HES
42
2
PCAR
40
-2
ETN
71
2
AMZN
58
2
CAH
69
2
CNX
53
3
CMS
67
9
ADM
42
5
PX
69
-3
ECL
45
-2
AMG
68
-7
PEP
27
-2
PFE
23
-5
OMC
40
-2
MCHP
62
11
SBUX
37
-2
WFC
75
-4
MAR
72
-2
WU
30
-2
LOW
53
-3
HES
42
2
PCAR
40
-2
ETN
71
2
AMZN
58
2
Financhill
Back

LifeStance Health Group 10K Form

Sell
28

LFST
LifeStance Health Group

Last Price:
$5.86
Seasonality Move:
-1.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive LFST News And Ratings

See the #1 stock for the next 7 days that we like better than LFST

LFST Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $-10.3M
Price / Cash Flow: 21.32
Annual Sales: $3.75
Price / Book: 1.53

Profitability

EPS (TTM): -0.10000
Net Income (TTM): $-35.6M
Gross Margin: $402.4M
Return on Equity: -2.48%
Return on Assets: -1.69%

LifeStance Health Group Earnings Forecast

Key LifeStance Health Group Financial Ratios

  • The Gross Profit Margin over the past 5 years for LFST is 32.17%.
  • The Selling, General & Administrative Expenses for LFST have been equal to 29.02% of Gross Profit Margin.
  • The Net Earning history of LFST is -4.59% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

LifeStance Health Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Providers & Services
Sector: Health Care
Current Symbol: LFST
Website: lifestance.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 1.47
Quick Ratio: 1.32

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 65.93

LFST Technical Analysis vs Fundamental Analysis

Sell
28
LifeStance Health Group (LFST) is a Sell

Is LifeStance Health Group a Buy or a Sell?